Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Raghunandan · SciRah

Researcher profile · Semantic Scholar

R. Raghunandan

Share profile

R. Raghunandan — researcher profile on SciRah

h-index: 17
Works: 40
Citations: 1,249

Most-cited papers

Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
Gale Smith, R. Raghunandan, Yingyun Wu, Ye V. Liu +8 more
2012PLoS ONE148 citations Open access
Semantic Scholar
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine.
G. Glenn, Gale Smith, L. Fries, R. Raghunandan +7 more
2013Vaccine140 citations
Semantic Scholar
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico
C. López-Macías, E. Ferat-Osorio, A. Tenorio-Calvo, A. Isibasi +11 more
2011Vaccine136 citations Open access
Semantic Scholar
Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
Gale Smith, D. Flyer, R. Raghunandan, Ye V. Liu +6 more
2013Vaccine117 citations Open access
Semantic Scholar
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
Wei-Na Sun, Yonghong Liu, Fatima Amanat, I. González-Domínguez +21 more
2021Nature Communications106 citations Open access
Semantic Scholar
H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans
Surender Khurana, Jian Wu, Nitin Verma, Swati Verma +8 more
2011Journal of Virology99 citations Open access
Semantic Scholar
Dlk1 Influences Differentiation and Function of β Lymphocytes
R. Raghunandan, M. Ruiz-Hidalgo, Yi-Feng Jia, R. Ettinger +6 more
2008Stem Cells and Development90 citations Open access
Semantic Scholar
Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages
Yevel Flores-Garcia, Sonia M. Herrera, Hugo Jhun, Daniel W. Pérez-Ramos +4 more
2019Malaria Journal75 citations Open access
Semantic Scholar
An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization
R. Raghunandan, Hanxin Lu, Bin Zhou, Mimi Guebre Xabier +5 more
2014Vaccine67 citations Open access
Semantic Scholar
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
P. Pitisuttithum, V. Luvira, S. Lawpoolsri, Sant Muangnoicharoen +43 more
2022EClinicalMedicine45 citations Open access
Semantic Scholar
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam
Anh Duc Dang, Thiem Dinh Vu, Ha Hai Vu, Van Thanh Ta +29 more
2022medRxiv39 citations Open access
Semantic Scholar
Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease.
B. Blanchard, R. Raghunandan, H. Roder, V. Ingram
1994Biochemical and Biophysical Research Communications - BBRC36 citations
Semantic Scholar
Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein
R. Raghunandan, B. Mayer, Yevel Flores-Garcia, Monica W. Gerber +7 more
2020Malaria Journal30 citations Open access
Semantic Scholar
RSV neutralization assays - Use in immune response assessment.
R. Raghunandan, Deborah Higgins, N. Hosken
2021Vaccine25 citations Open access
Semantic Scholar
Hyperphosphorylation of the cytoskeletal protein Tau by the MAP-kinase PK40erk2: regulation by prior phosphorylation with cAMP-dependent protein kinase A.
R. Raghunandan, V. M. Ingram
1995Biochemical and Biophysical Research Communications - BBRC25 citations Open access
Semantic Scholar
Virus-like particles: innate immune stimulators
R. Raghunandan
2011Expert Review of Vaccines24 citations
Semantic Scholar
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination
J. Carreño, A. Raskin, Gagandeep Singh, J. Tcheou +21 more
2023Science Translational Medicine20 citations Open access
Semantic Scholar
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial
P. Pitisuttithum, V. Luvira, S. Lawpoolsri, Sant Muangnoicharoen +42 more
2021medRxiv9 citations Open access
Semantic Scholar
A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters
Wei-Na Sun, Yonghong Liu, Fatima Amanat, I. González-Domínguez +21 more
2021bioRxiv6 citations Open access
Semantic Scholar
Preclinical Immunogenicity of a 6-Valent GBS Glycoconjugate Vaccine from a Repeat-Dose GLP Toxicology Study
Aakriti Bajracharya, Gowri Chellappan, Florence Seal, Yutai Zhao +15 more
2025Vaccines3 citations Open access
Semantic Scholar
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial
T. Vu, A. Dang, V. H. Ha, Thơm Văn Nguyễn +15 more
2024Vaccine3 citations Open access
Semantic Scholar
Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults
Kriengkrai Prasert, S. Nakphook, Jiraphut Kittiwatanachod, K. Sornwong +15 more
2026Vaccines2 citations Open access
Semantic Scholar
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil.
É. J. F. Peixoto de Miranda, R. T. Calado, F. Boulos, José Alfredo de Sousa Moreira +17 more
2025Vaccine2 citations
Semantic Scholar
One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in Thailand
W. Phumratanaprapin, V. Luvira, S. Lawpoolsri, Juthaporn Cowan +12 more
2025npj Vaccines1 citations Open access
Semantic Scholar
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines
J. Carreño, A. Raskin, Gagandeep Singh, J. Tcheou +21 more
2022medRxiv1 citations Open access
Semantic Scholar
Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 μg HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA.
Kriengkrai Prasert, S. Nakphook, Jiraphut Kittiwatanachod, Darunee Ditsungneon +18 more
2026Vaccine0 citations Open access
Semantic Scholar
All roads lead to Rome: N-acetylation of GBS Capsular Polysaccharides is linked to conjugate vaccine immunogenicity.
Gowri Chellappan, Aakriti Bajracharya, Yutai Zhao, Florence Seal +12 more
2026Carbohydrate Research0 citations
Semantic Scholar
Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults
P. Praphasiri, Darunee Ditsungneon, Anusak Kerdsin, S. Nakphook +17 more
2026Vaccines0 citations Open access
Semantic Scholar
Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S).
V. Luvira, S. Lawpoolsri, W. Phumratanaprapin, A. Jongkaewwattana +13 more
2025Vaccine0 citations Open access
Semantic Scholar
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: A Randomised, Comparator-Controlled, Phase 2 Trial
Thiem Dinh Vu, Anh Duc Dang, V. H. Ha, Thơm Văn Nguyễn +15 more
2023medRxiv0 citations Open access
Semantic Scholar
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3
J. Carreño, A. Raskin, Gagandeep Singh, J. Tcheou +23 more
20220 citations
Semantic Scholar
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3
J. Carreño, A. Raskin, Gagandeep Singh, J. Tcheou +23 more
20220 citations
Semantic Scholar
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3
J. Carreño, A. Raskin, Gagandeep Singh, J. Tcheou +23 more
20220 citations
Semantic Scholar
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3
J. Carreño, A. Raskin, Gagandeep Singh, Johnstone Tcheou +21 more
20220 citations
Semantic Scholar
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3
J. Carreño, A. Raskin, Gagandeep Singh, J. Tcheou +23 more
20220 citations
Semantic Scholar
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3
J. Carreño, A. Raskin, Gagandeep Singh, J. Tcheou +23 more
20220 citations
Semantic Scholar
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3
J. Carreño, A. Raskin, Gagandeep Singh, J. Tcheou +23 more
20220 citations
Semantic Scholar
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3
J. Carreño, A. Raskin, Gagandeep Singh, J. Tcheou +23 more
20220 citations
Semantic Scholar
Passive Immunization with RSV F Vaccine-Induced Polyclonal Antibodies Protect Cotton Rats From RSV A Challenge
Antia Fp, R. Raghunandan, Gale Smith, L. Fries +4 more
20130 citations
Semantic Scholar
Cell-Cell Interactions and Cell Fate Determination: Involvement of Dlk in B Cell Developmentand Function
R. Raghunandan, E. Rudikoff, S. Bauer
20060 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Krammer×18
Invite
F. Krammer — researcher profile on SciRah
Wei-Na Sun×16
Invite
Wei-Na Sun — researcher profile on SciRah
P. Palese×15
Invite
P. Palese — researcher profile on SciRah
S. Slamanig×14
Invite
S. Slamanig — researcher profile on SciRah

P. Pitisuttithum

×14

Invite

P. Pitisuttithum — researcher profile on SciRah

Sant Muangnoicharoen×14

Invite

Sant Muangnoicharoen — researcher profile on SciRah

J. Martinez×13

Invite

J. Martinez — researcher profile on SciRah

J. Carreño×13

Invite

J. Carreño — researcher profile on SciRah

Invite

A. Raskin — researcher profile on SciRah

Ponthip Wirachwong×12

Invite

Ponthip Wirachwong — researcher profile on SciRah

Invite

J. Tcheou — researcher profile on SciRah

A. García-Sastre×11

Invite

A. García-Sastre — researcher profile on SciRah